Central nervous system (CNS) metastasis will develop in 50% of small cell lung cancer
(SCLC) patients throughout disease course. Development of CNS metastasis poses a …

Background The efficacy of prophylactic cranial irradiation (PCI) in treating patients with
small cell lung cancer (SCLC) has not been clear, and recent randomized studies have …

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Small Cell Lung
Cancer (SCLC) provide recommended management for patients with SCLC, including …

Purpose Several sentinel phase III randomized trials have recently been published
challenging traditional radiation therapy (RT) practices for small cell lung cancer (SCLC) …

Currently, chemoimmunotherapy is the first-line treatment for extensive-stage small-cell lung
cancer (ES-SCLC). However, only 0.8%–2.5% of the patients presented complete response …

OBJECTIVE Prophylactic cranial irradiation (PCI) is a companion treatment option for small
cell lung cancer (SCLC) patients. However, its efficacy and associated risk factors have not …

Brain metastases (BMs) in extensive-stage small cell lung cancer (ES-SCLC) are often
associated with poor survival rates and quality of life, making the timely identification of high …

Purpose Brain metastases are common in patients with limited-stage small cell lung cancer
(LS-SCLC) due to the inability of most chemotherapeutics to penetrate the blood–brain …

COVID-19 has spread around the planet, sending billions of people into lockdown as health
services struggle to cope. Meanwhile in Asia, where the disease began, the spread …

Background and purpose The relationship between tumor-node-metastasis (TNM) stage
and patterns of failure in limited-stage small cell lung cancer (LS-SCLC) remains unclear …